ClassActionLawsuits.biz

According to a recent class action lawsuit filed in California, Enzyte manufacturer, Vianda, LLC, “is hiding a dangerous secret that they don’t want you to know: Enzyte causes heart arrhythmia that could cause sudden death.” Not only is Vianda a party to the lawsuit but so is CVS Caremark Corp. a pharmacy retailer. They have [...]

The latest decision by the U.S. Food and Drug Administration (FDA) might be the end for one of the most widely utilized prescription drug painkillers in the United States and has most likely laid the foundation for many many lawsuits to be filed against the drug companies that have manufactured it. In November 2010, the [...]

A federal judge recently approved a $110 million class-action settlement against the maker and distributor of an intravenous vitamin E supplement, E-Ferol, that government officials have said may be related to the deaths of dozens of premature infants in the mid-1980s. U.S. District Judge Sidney A. Fitzwater recently approved the settlement which was filed in [...]

Zyprexa, an antipsychotic drug also known as Olanzapine, normally prescribed for the treatment of schizophrenia and bipolar mania, has been linked to serious side effects including diabetes, hyperglycemia, pancreatitis, ketoacidosis, and diabetic coma.  To this point there have been 288 reported diabetes cases in Zyprexa patients, with 23 of them being fatal. The drug has [...]

Vioxx, the trade name of the generic drug rofecoxib, was approved by the U.S. Food and Drug Administration (FDA) in May 1999, for the treatment of osteoarthritis, menstrual pain and the management of acute pain in adults. On September 30, 2004 the manufacturer of Vioxx, Merck & Co., Inc. (Merck) announced that it was voluntarily [...]

December 19, 2002 — James J. McMonagle, Claims Administrator to the Sulzer Settlement Trust, announced today that the Trust is issuing payments totaling over $285,000,000 to approximately 5,500 claimants who have filed Claims arising from the implantation of certain hip and knee replacement joints manufactured by United States subsidiaries of Swiss medical device manufacturer, Sulzer [...]

Serzone, by Bristol-Myers Squibb Co. is a drug that is used by some physicians to treat depression. Serzone, also known as nefazodone hydrochloride, was put on the U.S. market with no warnings whatsoever regarding potential liver damage even though pre-clinical trials showed that there was the possibility of liver damage to humans. After Serzone was [...]

The Kahn Gauthier Law Group is investigating any possible lawsuit against drug manufacturer Pfizer to recover for injuries suffered by users of the now-withdrawn diabetes medication Rezulin (troglitazone). Rezulin was prescribed for type 2, or non-insulin dependent, diabetes patients who had not responded to other therapies. This type of diabetes typically is found in adults. [...]

On March 23, 2000, the US Food and Drug Administration (FDA) announced that Janssen Pharmaceutica (a wholly-owned subsidiary of Johnson & Johnson) would cease marketing of cisapride (Propulsid) in the United States as of July 14, 2000. In its announcement, the FDA stated that as of December 31, 1999, use of cisapride has been associated [...]

The Kahn Gauthier Law Group has commenced an investigation into any possible lawsuit against the manufacturers of Prempro. Federal investigators have made the startling announcement that Wyeth’s drug Prempro, an estrogen-progestin combination that millions of American women take to ease the symptoms of menopause, increases the risk of several serious ailments, including heart attack, stroke, [...]